James E. Voss
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral Infections and Vectors
Papers in
- Virology 16
- HIV Research and Treatment 16
-
- SARS-CoV-2 and COVID-19 Research 9
- Co-authors
- Felix Augusto Rey (2 shared papers)Elodie Crublet (1 shared paper)Andrew Thompson (1 shared paper)Christine Girard-Blanc (1 shared paper)Clemens Vonrhein (1 shared paper)M.C. Vaney (1 shared paper)S. Duquerroy (1 shared paper)G. Bricogne (1 shared paper)
- Journals
- The Journal of Immunology (4 papers)Cell Reports (3 papers)Science (3 papers)Immunity (3 papers)Nature Communications (3 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
James E. Voss
35 papers receiving 3.6k citations
James E. Voss's Hit Papers
Peers
Comparison fields: 5 of 96
- Virology 669
- Infectious Diseases 2.4k
- Animal Science and Zoology 351
- Immunology 657
- Public Health, Environmental and Occupational Health 726
Countries citing papers authored by James E. Voss
This map shows the geographic impact of James E. Voss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Voss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Voss more than expected).
Fields of papers citing papers by James E. Voss
This network shows the impact of papers produced by James E. Voss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Voss. The network helps show where James E. Voss may publish in the future.
Co-authors
The 25 scholars most cited alongside James E. Voss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model Hit paper breakdown → | 2020 | 981 |
| 2 | Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography Hit paper breakdown → | 2010 | 546 |
| 3 | 2020 | 419 | |
| 4 | 2011 | 251 | |
| 5 | Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody Hit paper breakdown → | 2021 | 229 |
| 6 | 2021 | 209 | |
| 7 | 2016 | 193 | |
| 8 | 2015 | 158 | |
| 9 | 2019 | 68 | |
| 10 | 2022 | 67 | |
| 11 | 2020 | 59 | |
| 12 | 2020 | 58 | |
| 13 | 2014 | 56 | |
| 14 | 2017 | 54 | |
| 15 | 2020 | 51 | |
| 16 | 2017 | 49 | |
| 17 | 2022 | 42 | |
| 18 | 2020 | 28 | |
| 19 | 2022 | 26 | |
| 20 | 2015 | 23 |
About James E. Voss
James E. Voss is a scholar working on Virology, Infectious Diseases, Radiology, Nuclear Medicine and Imaging, Immunology and Animal Science and Zoology, having authored 36 papers that have together received 3.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (16 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Immune Cell Function and Interaction (5 papers), Glycosylation and Glycoproteins Research (4 papers), CAR-T cell therapy research (4 papers), T-cell and B-cell Immunology (4 papers) and CRISPR and Genetic Engineering (3 papers). The work is most often cited by research in Virology (669 citations), Infectious Diseases (2.4k citations), Animal Science and Zoology (351 citations), Immunology (657 citations) and Public Health, Environmental and Occupational Health (726 citations). James E. Voss has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Felix Augusto Rey, Elodie Crublet, Andrew Thompson, Christine Girard-Blanc, Clemens Vonrhein, M.C. Vaney, S. Duquerroy, G. Bricogne, Dennis R. Burton and Laura E. McCoy. Their work appears in journals such as The Journal of Immunology, Cell Reports, Science, Immunity and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.